OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TREM2‐dependent microglial function is essential for remyelination and subsequent neuroprotection
Yuanyuan Wang, Roxanne V. Kyauk, Yun‐An A. Shen, et al.
Glia (2023) Vol. 71, Iss. 5, pp. 1247-1258
Open Access | Times Cited: 23

Showing 23 citing articles:

Microglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances
Qianting Deng, Chongyun Wu, Emily M. Parker, et al.
Aging and Disease (2023)
Open Access | Times Cited: 27

Microglia and TREM2
Jennifer M. Pocock, Foteini Vasilopoulou, Elina Svensson, et al.
Neuropharmacology (2024) Vol. 257, pp. 110020-110020
Closed Access | Times Cited: 11

TREM2 deficiency impairs the energy metabolism of Schwann cells and exacerbates peripheral neurological deficits
Nannan Zhang, Qingjie Ji, Yunfeng Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 9

Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer's Disease and Multiple Sclerosis
Ainhoa Etxeberría, Yun‐An A. Shen, Stephen Vito, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 29, pp. e2347232024-e2347232024
Closed Access | Times Cited: 8

Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis
J.Q. Alida Chen, Dennis Wever, Niamh B. McNamara, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1

Recognizing Alzheimer's disease from perspective of oligodendrocytes: Phenomena or pathogenesis?
Jingji Wang, Yilan Zhen, Jun Yang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 7

TREM2 alleviates white matter injury after traumatic brain injury in mice might be mediated by regulation of DHCR24/LXR pathway in microglia
Li Zhao, Shenghui Yu, Lin Li, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 7

Mechanisms underlying the beneficial effects of physical exercise on multiple sclerosis: focus on immune cells
Boyi Zong, Fengzhi Yu, Xiaoyou Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12

Identifying Biomarkers for Remyelination and Recovery in Multiple Sclerosis: A Measure of Progress
Vito A. G. Ricigliano, Silvia Marenna, Serena Borrelli, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 357-357
Open Access

TREM2 activation reduces white matter injury via PI3K/Akt/GSK‐3β signalling after intracerebral haemorrhage
Yuan Zhang, Shi You, Lin Wang, et al.
British Journal of Pharmacology (2025)
Closed Access

TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies
Lianshuai Zhang, Xianyuan Xiang, Y. Li, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access

Montelukast improves disease outcome in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity
Stefano Raffaele, Nhung Nguyen, Marco Milanese, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 18, pp. 3303-3326
Open Access | Times Cited: 3

Single-cell sequencing reveals glial cell involvement in development of neuropathic pain via myelin sheath lesion formation in the spinal cord
Danyang Li, Kaihong Yang, Jinlu Li, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3

Alzheimer’s disease: an axonal injury disease?
Dan Liang, Zhaohui Zhang
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 8

Repurposing of pexidartinib for microglia depletion and renewal
Marc-Philipp Weyer, Jenny Strehle, Michael K. E. Schäfer, et al.
Pharmacology & Therapeutics (2023) Vol. 253, pp. 108565-108565
Closed Access | Times Cited: 6

Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonism
Stephen Schauer, Chang Hoon Cho, Gloriia Novikova, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 5861-5888
Open Access | Times Cited: 2

Trem2-deficiency aggravates and accelerates age-related myelin degeneration
Tyler J. McCray, Logan M Bedford, Stephanie J. Bissel, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2

The emerging role of microglia in the development and therapy of multiple sclerosis
Yunrong Nan, Shuting Ni, Mei Liu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113476-113476
Closed Access | Times Cited: 1

Galectin-3 alleviates demyelination by modulating microglial anti-inflammatory polarization through PPARγ-CD36 axis
Qian Wang, Fansen Zeng, Chunxiao Fang, et al.
Brain Research (2024) Vol. 1842, pp. 149106-149106
Closed Access

Cerebellar white matter development is regulated by fractalkine-dependent microglia phagocytosis of oligodendrocyte progenitor cells
McKenzie K. Chappell, John Shelestak, Muhammad Irfan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

TREM2 and APOE do not modulate phagocytic clearance of dying cells in the live mammalian brain
Eyiyemisi C. Damisah, Anupama Rai, Robert Hill, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Glia in Recovery Processes and Repair
Wolfgang Walz
Springer eBooks (2023), pp. 231-240
Closed Access

Page 1

Scroll to top